View Future GrowthAlbemarle 과거 순이익 실적과거 기준 점검 0/6Albemarle 의 수입은 연평균 -33.8%의 비율로 감소해 온 반면, Chemicals 산업은 연평균 8%의 비율로 증가했습니다. 매출은 연평균 7.1%의 비율로 증가해 왔습니다.핵심 정보-33.80%순이익 성장률-33.98%주당순이익(EPS) 성장률Chemicals 산업 성장률23.20%매출 성장률7.13%자기자본이익률-1.84%순이익률-7.27%최근 순이익 업데이트31 Mar 2026최근 과거 실적 업데이트Reported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.공시 • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026공시 • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.공시 • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.공시 • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025모든 업데이트 보기Recent updatesReported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.공시 • May 07Albemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.공시 • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026공시 • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.공시 • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United States공시 • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.공시 • Feb 27Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026.공시 • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.공시 • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026공시 • Dec 13Albemarle Corporation Announces Resignation of Dean L. Seavers as Director, Effective December 12, 2025Albemarle Corporation announced that Dean L. Seavers tendered his resignation from the Board of Directors and all committees on which he serves, effective December 12, 2025.Upcoming Dividend • Dec 04Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 11 December 2025. Payment date: 02 January 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 1.3%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.9%).Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.공시 • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.Declared Dividend • Oct 31Dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 11th December 2025 Payment date: 2nd January 2026 Dividend yield will be 1.4%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.공시 • Oct 28Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on January 2, 2026The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025.공시 • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025공시 • Aug 12Albemarle Announces Executive Changes, Effective August 11, 2025Albemarle Corporation announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of August 11, 2025: Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company. Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience. Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.Reported Earnings • Jul 31Second quarter 2025 earnings released: EPS: US$0.20 (vs US$1.96 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.20 (up from US$1.96 loss in 2Q 2024). Revenue: US$1.33b (down 7.0% from 2Q 2024). Net income: US$22.9m (up US$252.8m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.공시 • Jul 31Albemarle Corporation Announces Executive Changeslbemarle Corporation announced that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary, and chief compliance officer. Krupa joined Albemarle in May 2017 as vice president, deputy general counsel, and assistant corporate secretary. He has served in leadership roles supporting Albemarle's global business units, commercial activities, and mergers and acquisitions. Krupa has more than 15 years of practice in the manufacturing industry and deep experience across Albemarle's businesses. Prior to Albemarle, Krupa served as assistant general counsel, governance, and securities for BWX Technologies Inc. and The Babcock & Wilcox Company. He was also an attorney with the international law firm of Greenberg Traurig LLP in the firm's corporate and securities practice group. Krupa received a bachelor's degree from the University of Georgia and earned his J.D. from Georgia State University College of Law. He is based in the company's Charlotte, N.C., headquarters and will report to Kent Masters as part of Albemarle's executive leadership team. Krupa assumes the role following the passing in April of Albemarle's former general counsel, corporate secretary, and chief compliance officer, Stacy Grant, at which time he was named as interim general counsel.공시 • Jul 23Albemarle Corporation Declares Quarterly Common Stock Dividend, Payable on October 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025.공시 • Jun 19Albemarle Corporation to Report Q2, 2025 Results on Jul 30, 2025Albemarle Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025Buy Or Sell Opportunity • May 30Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €49.88. The fair value is estimated to be €62.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 1.7% in a year. Earnings are forecast to grow by 100% in the next year.공시 • May 07Albemarle Announces Quarterly Common Stock Dividend, Payable on July 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025.Board Change • May 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Ralf Cramer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역Albemarle가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BIT:1ALB 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Mar 265,495-4005594631 Dec 255,143-6775435130 Sep 254,946-1885035930 Jun 254,993-1,0965236931 Mar 255,094-1,3075587731 Dec 245,378-1,3165958730 Sep 246,502-1,9676478930 Jun 247,458-5546558831 Mar 248,3983266548931 Dec 239,6171,5738698630 Sep 239,8823,3245708330 Jun 239,6633,9185328031 Mar 238,7733,6754837631 Dec 227,3202,6904397230 Sep 225,5931,5543936430 Jun 224,3322643655931 Mar 223,6262813635531 Dec 213,3281243335430 Sep 213,3132124505730 Jun 213,2297034395831 Mar 213,2193644185831 Dec 203,1293764275930 Sep 203,2423824115830 Jun 203,3754384306031 Mar 203,4965074535931 Dec 193,5895334705830 Sep 193,5195724406030 Jun 193,4175474326131 Mar 193,3856954176431 Dec 183,3756944157030 Sep 183,3113464107530 Jun 183,2883354168031 Mar 183,1721354218131 Dec 173,072554207930 Sep 172,9113154317730 Jun 172,8103024167531 Mar 172,7422823967831 Dec 162,6774423557930 Sep 162,7035603038230 Jun 162,7425102978431 Mar 162,7914682998631 Dec 152,8263023008930 Sep 152,7021243978930 Jun 152,65214938289양질의 수익: 1ALB 은(는) 현재 수익성이 없습니다.이익 마진 증가: 1ALB는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 1ALB은 수익성이 없으며 지난 5년 동안 손실이 연평균 33.8% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 1ALB의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: 1ALB은 수익성이 없어 지난 해 수익 성장률을 Chemicals 업계(-36.9%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 1ALB는 현재 수익성이 없으므로 자본 수익률이 음수(-1.84%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/18 05:56종가2026/05/15 00:00수익2026/03/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Albemarle Corporation는 37명의 분석가가 다루고 있습니다. 이 중 18명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관William SeleskyArgus Research CompanyBenjamin KalloBairdAndres Castanos-MollorBerenberg34명의 분석가 더 보기
Reported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.
공시 • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026
공시 • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026
Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.
공시 • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.
공시 • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025
Reported Earnings • May 11First quarter 2026 earnings released: EPS: US$2.35 (vs US$0.003 loss in 1Q 2025)First quarter 2026 results: EPS: US$2.35 (up from US$0.003 loss in 1Q 2025). Revenue: US$1.43b (up 33% from 1Q 2025). Net income: US$277.4m (up US$277.7m from 1Q 2025). Profit margin: 19% (up from 0% in 1Q 2025). Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe.
공시 • May 07Albemarle Corporation announces Quarterly dividend, payable on July 01, 2026Albemarle Corporation announced Quarterly dividend of USD 0.4050 per share payable on July 01, 2026, ex-date on June 12, 2026 and record date on June 12, 2026.
공시 • Apr 07Albemarle Corporation to Report Q1, 2026 Results on May 06, 2026Albemarle Corporation announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 06, 2026
공시 • Mar 25Albemarle Corporation Announces Director James O’Brien Will Not Stand for Re-Election, Effective May 5, 2026Albemarle Corporation announced James O’Brien, director will not stand for reelection. James O’Brien's directorship will end effective at the Annual Meeting to be held on May 5, 2026 pursuant to attained the age of 72 in 2026, and, accordingly, is not nominated for re-election at this annual meeting.
공시 • Mar 12Albemarle Corporation, Annual General Meeting, May 05, 2026Albemarle Corporation, Annual General Meeting, May 05, 2026. Location: 4250 congress street north carolina 28209, charlotte, United States
공시 • Mar 03+ 1 more updateKPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB).KPS Capital Partners, LP entered into a Stock Purchase Agreement to acquire Ketjen Corporation from Albemarle Corporation (NYSE:ALB) for $800 million on October 25, 2025. Under the terms of the Stock Purchase Agreement, Albemarle Corporation will sell 51% of the common stock of Ketjen (Purchased Shares) to KPS Capital Partners and contribute remaining 49% of common stock of Ketjen to Holdco, that was organized by and is affiliated with KPS Capital Partners LP. At the closing of the sale, contribution and other transactions contemplated by the Stock Purchase Agreement (collectively, the “Transaction”), Albemarle will receive an estimated $536 million in cash and will own common units of Holdco (the “Rollover Equity”). Under the Stock Purchase Agreement, the purchase price for the Purchased Shares is $800.0 million, less the value ascribed to the Contributed Shares pursuant to the terms and conditions of the Stock Purchase Agreement, and is further subject to adjustment for closing cash, indebtedness, net working capital and transaction expenses. Albemarle and KPS, through affiliates, will own approximately 49% and 51% of Ketjen at close, respectively, with KPS having a majority of the Board of Directors and operational control of Ketjen. The debt financing has been provided by Barclays, Jefferies, BNP Paribas and Santander. The termination fee of $32.5 million has to be paid by KPS Capital Partners, LP to Albemarle Corporation, if the closing has not occurred by April 30, 2026. The transactions is expected to be completed in the first half of 2026, with both subject to customary closing conditions and regulatory approvals, including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”), as well as approvals from competition and foreign investment authorities from certain non-U.S. jurisdictions and certain other governmental authorities. Goldman Sachs & Co. LLC acted as financial advisor and K&L Gates LLP acted as legal advisor for Albemarle Corporation. Paul, Weiss, Rifkind, Wharton & Garrison LLP acted as legal advisor and Raymond James Financial, Inc. acted as financial advisor for KPS Capital Partners, LP. Roel Fluit, Michel van Agt, Guido Koop, and Vincent van der Lans of Loyens & Loeff acted as legal advisor to KPS Capital Partners. KPS Capital Partners, LP completed the acquisition of 51% stake in Ketjen Corporation from Albemarle Corporation (NYSE:ALB) on March 2, 2026. Albemarle will retain reamining 49% stake in Ketjen.
공시 • Feb 27Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on April 1, 2026The Board of Directors of Albemarle Corporation announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable April 1, 2026, to shareholders of record at the close of business as of March 13, 2026.
공시 • Feb 12+ 2 more updatesAlbemarle Corporation Provides Earnings Guidance for 2026Albemarle Corporation provided earnings guidance for 2026. For the period the company expects the Net sales of $5.7 billion to $6.0 billion. Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.
공시 • Jan 14Albemarle Corporation to Report Q4, 2025 Results on Feb 11, 2026Albemarle Corporation announced that they will report Q4, 2025 results After-Market on Feb 11, 2026
공시 • Dec 13Albemarle Corporation Announces Resignation of Dean L. Seavers as Director, Effective December 12, 2025Albemarle Corporation announced that Dean L. Seavers tendered his resignation from the Board of Directors and all committees on which he serves, effective December 12, 2025.
Upcoming Dividend • Dec 04Upcoming dividend of US$0.41 per shareEligible shareholders must have bought the stock before 11 December 2025. Payment date: 02 January 2026. The company is not currently making a profit and there are not enough cash flows to support it either. Trailing yield: 1.3%. Lower than top quartile of Italian dividend payers (4.9%). Lower than average of industry peers (2.9%).
Reported Earnings • Nov 06Third quarter 2025 earnings released: US$1.72 loss per share (vs US$9.45 loss in 3Q 2024)Third quarter 2025 results: US$1.72 loss per share (improved from US$9.45 loss in 3Q 2024). Revenue: US$1.31b (down 3.5% from 3Q 2024). Net loss: US$202.4m (loss narrowed 82% from 3Q 2024). Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 7.7% growth forecast for the Chemicals industry in Italy.
공시 • Nov 06+ 1 more updateAlbemarle Corporation Announces Goodwill Impairment Charges for the Third Quarter Ended September 30, 2025Albemarle Corporation announced Goodwill impairment charges for the third quarter ended September 30, 2025. For the period, the company reported Goodwill impairment charges of $181,070,000.
Declared Dividend • Oct 31Dividend of US$0.41 announcedShareholders will receive a dividend of US$0.41. Ex-date: 11th December 2025 Payment date: 2nd January 2026 Dividend yield will be 1.4%, which is lower than the industry average of 2.8%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 3.4% per year over the past 10 years and has been stable with no material reductions to payments, indicating a long track record of dividend growth and stability.
공시 • Oct 28Albemarle Corp. Announces Quarterly Common Stock Dividend, Payable on January 2, 2026The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable January 2, 2026, to shareholders of record at the close of business as of December 12, 2025.
공시 • Sep 26Albemarle Corporation to Report Q3, 2025 Results on Nov 05, 2025Albemarle Corporation announced that they will report Q3, 2025 results After-Market on Nov 05, 2025
공시 • Aug 12Albemarle Announces Executive Changes, Effective August 11, 2025Albemarle Corporation announced changes to its organizational structure to further align the company for agility and efficiency. These enhancements are designed to accelerate the company's market-led enterprise strategy and focus on operational excellence. Effective as of August 11, 2025: Mark Mummert will lead an integrated function of resources, manufacturing, capital and supply chain as chief operations officer continuing to report to Kent Masters, Albemarle's chairman and CEO. In this role, he will ensure optimization of Albemarle's world-class resources, including joint venture management, as well as global manufacturing. In addition, he will oversee capital projects and supply chain in a fully integrated operating model. With this change, Netha Johnson is leaving the company. Autumn Gagarinas will become Albemarle's chief people and workplace transformation officer, also reporting to Masters, to focus on talent and culture, as well as business process and technology optimization. Autumn has been serving as Albemarle's vice president of human resources for over two years and has over two decades of human resources experience. Melissa Anderson will continue to report to Masters and will lead Albemarle's enterprise strategy and growth, as well as research and technology as chief business transformation officer.
Reported Earnings • Jul 31Second quarter 2025 earnings released: EPS: US$0.20 (vs US$1.96 loss in 2Q 2024)Second quarter 2025 results: EPS: US$0.20 (up from US$1.96 loss in 2Q 2024). Revenue: US$1.33b (down 7.0% from 2Q 2024). Net income: US$22.9m (up US$252.8m from 2Q 2024). Profit margin: 1.7% (up from net loss in 2Q 2024). Revenue is forecast to grow 9.5% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Chemicals industry in Italy.
공시 • Jul 31Albemarle Corporation Announces Executive Changeslbemarle Corporation announced that Ander Krupa has been promoted to executive vice president, general counsel, corporate secretary, and chief compliance officer. Krupa joined Albemarle in May 2017 as vice president, deputy general counsel, and assistant corporate secretary. He has served in leadership roles supporting Albemarle's global business units, commercial activities, and mergers and acquisitions. Krupa has more than 15 years of practice in the manufacturing industry and deep experience across Albemarle's businesses. Prior to Albemarle, Krupa served as assistant general counsel, governance, and securities for BWX Technologies Inc. and The Babcock & Wilcox Company. He was also an attorney with the international law firm of Greenberg Traurig LLP in the firm's corporate and securities practice group. Krupa received a bachelor's degree from the University of Georgia and earned his J.D. from Georgia State University College of Law. He is based in the company's Charlotte, N.C., headquarters and will report to Kent Masters as part of Albemarle's executive leadership team. Krupa assumes the role following the passing in April of Albemarle's former general counsel, corporate secretary, and chief compliance officer, Stacy Grant, at which time he was named as interim general counsel.
공시 • Jul 23Albemarle Corporation Declares Quarterly Common Stock Dividend, Payable on October 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. The dividend, which has an annualized rate of $1.62, is payable October 1, 2025, to shareholders of record at the close of business as of September 12, 2025.
공시 • Jun 19Albemarle Corporation to Report Q2, 2025 Results on Jul 30, 2025Albemarle Corporation announced that they will report Q2, 2025 results After-Market on Jul 30, 2025
Buy Or Sell Opportunity • May 30Now 21% undervaluedThe stock has been flat over the last 90 days, currently trading at €49.88. The fair value is estimated to be €62.74, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Meanwhile, the company became loss making. Revenue is forecast to decline by 1.7% in a year. Earnings are forecast to grow by 100% in the next year.
공시 • May 07Albemarle Announces Quarterly Common Stock Dividend, Payable on July 1, 2025The Board of Directors of Albemarle Corp. announced that it declared a quarterly common stock dividend of $0.405 per share. This marks Albemarle's 126th consecutive quarterly cash dividend. The dividend, which has an annualized rate of $1.62, is payable July 1, 2025, to shareholders of record at the close of business as of June 13, 2025.
Board Change • May 02Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 6 experienced directors. 4 highly experienced directors. Independent Director Ralf Cramer was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.